Welcome to our dedicated page for KOHLS SEC filings (Ticker: KSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on KOHLS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into KOHLS's regulatory disclosures and financial reporting.
KOHLS Corp (symbol: KSS) is the issuer of record for a Form 4 filing submitted to the SEC.
KOHLS Corp (KSS) director Wendy C. Arlin reported an acquisition of 8,850 shares of common stock in the form of deferred restricted stock units granted under the company’s Long-Term Compensation Plan. These units vest in full on the first anniversary of the grant date, bringing her total direct holdings to 63,748 shares, including 25,338 unvested deferred restricted stock units.
American Century entities reported passive ownership of Kohl's Corporation common stock. American Century ETF Trust reported beneficial ownership of 5,962,061 shares, representing 5.3% of Kohl's outstanding common stock, with sole voting and dispositive power over these shares.
American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each reported beneficial ownership of 6,227,914 shares, or 5.5% of the class, all with sole voting and sole dispositive power. The filing notes that various advisory clients of American Century Investment Management have the right to receive dividends or sale proceeds, but no single client holds more than 5% of the class.
KOHLS Corp senior executive Raymond Christie, Sr. EVP and Chief Marketing Officer, reported a sale of 15,000 shares of common stock on August 3, 2026 at a weighted average price of $20.00 per share, with individual trades ranging from $20.00 to $20.02. Following the transaction, he reports beneficial ownership of 261,720 shares, which includes 142,111 unvested restricted stock units. The sale was executed automatically under a previously disclosed Rule 10b5-1 trading plan adopted on April 6, 2026.
Kohl's Corp executive Jennifer J. Kent, Sr. EVP, CLO & Corp. Sec., sold 22,942 shares of Common Stock on August 3, 2026 at a weighted average price of $20.00 per share, in multiple transactions priced from $20.00 to $20.02, under a previously disclosed Rule 10b5-1 trading plan adopted on March 13, 2026.
After this sale, she directly holds 234,452 shares, including 123,831 unvested restricted stock units.
KSS has filed to sell up to 22,942 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $458,850.17. Shares outstanding totaled 113,399,993. Recent share acquisitions include restricted stock vesting grants in March and April 2025 used as compensation.
Kohl's Corporation insider filed to sell common stock through Fidelity Brokerage Services LLC. The filing covers 15,000 shares of common stock, with a stated aggregate value of $300,004.00, to be sold on the NYSE on August 3, 2026.
The filing also lists prior acquisitions of common shares through restricted stock vesting granted by the issuer as compensation on several dates from March 25, 2023 through June 25, 2025, including 5,861 shares on June 15, 2024 and 8,548 shares on September 15, 2024.
Kohls Corp director Niren Chaudhary has filed an initial insider ownership report as a reporting person of the company. The Form 3 identifies his role as a director and shows no reported transactions, holdings entries, or derivative positions.
Kohl’s Corporation announced that longtime director and independent Chair John E. Schlifske retired from the Board and stepped down as Chair effective July 28, 2026, citing personal reasons and no disagreement with the company. The Board unanimously appointed current independent director Wendy Arlin as Chair, effective immediately, and added Niren Chaudhary as a new independent director to fill the resulting vacancy. Chaudhary will serve on the Audit Committee and, as a non-employee director, is expected to receive an equity award of restricted shares with a grant date fair value of approximately $145,000 on August 14, 2026, vesting on the first anniversary of the grant date under the company’s Non-Employee Director Compensation Program.
Kohl's Corp Senior EVP and Chief People Officer Mari Steinmetz reported several equity compensation-related stock movements. She received 107 common shares as dividend-equivalent credits on vested restricted stock units and had 189 shares withheld to cover tax obligations. She also completed an open-market sale of 53 shares at $17.17 per share under a previously adopted Rule 10b5-1 trading plan. After these transactions she directly holds 243,119 common shares, and this total includes 217,862 unvested restricted stock units.